Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “UNICYCIVE THERAPEUTICS, INC.”

4 pharma patents match "UNICYCIVE THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "UNICYCIVE THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “UNICYCIVE THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12396989

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted

  2. US 12377082

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

  3. US 12036211

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted

  4. US 11406663

    Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

    UNICYCIVE THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.